Stay updated with breaking news from Ignacio Melero. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Mass., April 24, 2024 -- Cullinan Therapeutics, Inc. , a biopharmaceutical company focused on modality-agnostic targeted therapies, today announced that clinical data from its Phase 1...
RESEARCHERS at Navarra's Cima University believe that a new combination of immunotherapy treatment could be used to fight liver cancer, and are testing
Spanish researchers at Cima University of Navarra have developed a new immunotherapy combination that improves efficacy in animal models of hepatocellular carcinoma. This is a proof of concept that lays the foundations for the application of this treatment in patients with the most common liver cancer.
Eight patients responded positively to an experimental treatment that combined a vaccine using mRNA tailored to each patient’s tumor and conventional drugs
- Internationally renowned researchers Gordon Freeman, Ph.D., Thomas Gajewski, M.D., Ph.D., Jason Luke, M.D., Ignacio Melero, M.D., Ph.D., and Anthony...